Critical role for the catalytic activity of phospholipase C-γ1 in epidermal growth factor-induced cell migration

Biochemical and Biophysical Research Communications

Volumn 399, Issue 3, 2010, Pages 425-428

  Xie, Zhongjian ^a,b   Peng, Jian ^b   Pennypacker, Sally D ^a   Chen, Ying ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Catalytic activity; Epidermal growth factor receptor; Migration; Phospholipase C 1

Indexed keywords

CALCIUM; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; INOSITOL 1,4,5 TRISPHOSPHATE; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA1;

ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CATALYSIS; CELL MIGRATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

CALCIUM; CATALYSIS; CELL LINE, TUMOR; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; NEOPLASM INVASIVENESS; PHOSPHOLIPASE C GAMMA; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 77956173049     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.07.098     Document Type: Article

References (31)

1. Wells A. EGF receptor. Int. J. Biochem. Cell Biol. 1999, 31:637-643.
2. Carpenter G., Ji Q. Phospholipase C-gamma as a signal-transducing element. Exp. Cell Res. 1999, 253:15-24.
3. Arteaga C.L., Johnson M.D., Todderud G., Coffey R.J., Carpenter G., Page D.L. Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc. Natl. Acad. Sci. USA 1991, 88:10435-10439.
4. Noh D.Y., Lee Y.H., Kim S.S., Kim Y.I., Ryu S.H., Suh P.G., Park J.G. Elevated content of phospholipase C-gamma 1 in colorectal cancer tissues. Cancer 1994, 73:36-41.
5. Xie Z., Chen Y., Liao E.Y., Jiang Y., Liu F.Y., Pennypacker S.D. Phospholipase C-gamma1 is required for the epidermal growth factor receptor-induced squamous cell carcinoma cell mitogenesis. Biochem. Biophys. Res. Commun. 2010, 397:296-300.
6. Chen P., Xie H., Sekar M.C., Gupta K., Wells A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J. Cell Biol. 1994, 127:847-857.
7. Polk D.B. Epidermal growth factor receptor-stimulated intestinal epithelial cell migration requires phospholipase C activity. Gastroenterology 1998, 114:493-502.
8. Price J.T., Tiganis T., Agarwal A., Djakiew D., Thompson E.W. Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase C-dependent mechanism. Cancer Res. 1999, 59:5475-5478.
9. Khoshyomn S., Penar P.L., Rossi J., Wells A., Abramson D.L., Bhushan A. Inhibition of phospholipase C-gamma1 activation blocks glioma cell motility and invasion of fetal rat brain aggregates. Neurosurgery 1999, 44:568-577. discussion 577-568.
10. Thomas S.M., Coppelli F.M., Wells A., Gooding W.E., Song J., Kassis J., Drenning S.D., Grandis J.R. Epidermal growth factor receptor-stimulated activation of phospholipase C-gamma1 promotes invasion of head and neck squamous cell carcinoma. Cancer Res. 2003, 63:5629-5635.
11. Shien T., Doihara H., Hara H., Takahashi H., Yoshitomi S., Taira N., Ishibe Y., Teramoto J., Aoe M., Shimizu N. PLC and PI3K pathways are important in the inhibition of EGF-induced cell migration by gefitinib ('Iressa', ZD1839). Breast Cancer 2004, 11:367-373.
12. Nozawa H., Howell G., Suzuki S., Zhang Q., Qi Y., Klein-Seetharaman J., Wells A., Grandis J.R., Thomas S.M. Combined inhibition of PLC-gamma1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion. Clin. Cancer Res. 2008, 14:4336-4344.
13. Dittmar T., Husemann A., Schewe Y., Nofer J.R., Niggemann B., Zanker K.S., Brandt B.H. Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR. FASEB J. 2002, 16:1823-1825.
14. Bleasdale J.E., Thakur N.R., Gremban R.S., Bundy G.L., Fitzpatrick F.A., Smith R.J., Bunting S. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J. Pharmacol. Exp. Ther. 1990, 255:756-768.
15. Smith R.J., Sam L.M., Justen J.M., Bundy G.L., Bala G.A., Bleasdale J.E. Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. J. Pharmacol. Exp. Ther. 1990, 253:688-697.
16. Jiang C.K., Connolly D., Blumenberg M. Comparison of methods for transfection of human epidermal keratinocytes. J. Invest. Dermatol. 1991, 97:969-973.
17. Xie Z., Bikle D.D. Phospholipase C-gamma1 is required for calcium-induced keratinocyte differentiation. J. Biol. Chem. 1999, 274:20421-20424.
18. Xie Z., Bikle D.D. Inhibition of 1, 25-dihydroxyvitamin-D-induced keratinocyte differentiation by blocking the expression of phospholipase C-gamma1. J. Invest. Dermatol. 2001, 117:1250-1254.
19. Sun H.-Q., Lin K.-M., Yin H.L. Gelsolin modulates phospholipase C activity in vivo through phospholipid binding. J. Cell Biol. 1997, 138:811-820.
20. Xie Z., Bikle D.D. The recruitment of phosphatidylinositol 3-kinase to the E-cadherin-catenin complex at the plasma membrane is required for calcium-induced phospholipase C-gamma1 activation and human keratinocyte differentiation. J. Biol. Chem. 2007, 282:8695-8703.
21. Xie Z., Chang S.M., Pennypacker S.D., Liao E.Y., Bikle D.D. Phosphatidylinositol-4-phosphate 5-kinase 1alpha mediates extracellular calcium-induced keratinocyte differentiation. Mol. Biol. Cell 2009, 20:1695-1704.
22. Xie Z., Singleton P.A., Bourguignon L.Y., Bikle D.D. Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-gamma1. Mol. Biol. Cell 2005, 16:3236-3246.
23. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
24. Mouneimne G., Soon L., DesMarais V., Sidani M., Song X., Yip S.C., Ghosh M., Eddy R., Backer J.M., Condeelis J. Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation. J. Biol. Chem. 2004, 166:697-708.
25. 2+ concentration. Cell. Signal. 2009, 21:1698-1705.
26. Etienne-Manneville S., Manneville J.B., Adamson P., Wilbourn B., Greenwood J., Couraud P.O. ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines. J. Immunol. 2000, 165:3375-3383.
27. Hofman P., d'Andrea L., Guzman E., Selva E., Le Negrate G., Far D.F., Lemichez E., Boquet P., Rossi B. Neutrophil F-actin and myosin but not microtubules functionally regulate transepithelial migration induced by interleukin 8 across a cultured intestinal epithelial monolayer. Eur. Cytokine Netw. 1999, 10:227-236.
28. Hwang Y.P., Jeong H.G. Metformin blocks migration and invasion of tumor cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase C-alpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1. Br. J. Pharmacol. 2010, 160:1195-1211.
29. Mertens-Walker I., Bolitho C., Baxter R.C., Marsh D.J. Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1/2 activation regulated by calcium and protein kinase C-delta. Endocr. Relat. Cancer 2010, 17:335-349.
30. Hirai K., Yoshioka H., Kihara M., Hasegawa K., Sakamoto T., Sawada T., Fushiki S. Inhibiting neuronal migration by blocking NMDA receptors in the embryonic rat cerebral cortex: a tissue culture study. Brain Res. 1999, 114:63-67.
31. Saito H., Minamiya Y., Kitamura M., Saito S., Enomoto K., Terada K., Ogawa J. Endothelial myosin light chain kinase regulates neutrophil migration across human umbilical vein endothelial cell monolayer. J. Immunol. 1998, 161:1533-1540.